Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Rubin

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of Molecular Biology|October 22, 2013
Binding of MgtR, a Salmonella transmembrane regulatory peptide, to MgtC, a Mycobacterium tuberculosis virulence factor: a structural studyFrantz L Jean-Francois, Jian Dai, Lu Yu, et al.
NEJM Evidence|February 6, 2024
<i>NEJM Evidence</i> - A New Journal in the NEJM Group FamilyChana A Sacks, C Corey Hardin, Sharon-Lise Normand, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 28, 2003
A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancyDeborah L Toppmeyer, Murugesan Gounder, Judie Much, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 26, 2003
Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignanciesRobert S DiPaola, Eric Rubin, Deb Toppmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working GroupLia Gore, S Percy Ivy, Frank M Balis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2016
Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibodyJean-Marie Michot, Renaud Mazeron, Laurent Dercle, et al.
Molecular Cancer Therapeutics|November 8, 2011
MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosisYan Cheng, Yi Zhang, Li Zhang, et al.
Annals of Internal Medicine|March 6, 2023
<i>Mycobacterium abscessus</i> Cluster in Cardiac Surgery Patients Potentially Attributable to a Commercial Water Purification SystemMichael Klompas, Chidiebere Akusobi, Jon Boyer, et al.
Journal of Bacteriology|May 18, 2010
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratoriesThomas R Ioerger, Yicheng Feng, Krishna Ganesula, et al.
NEJM Evidence|December 17, 2025
Public Health Alerts - A New Section in <i>NEJM Evidence</i>, in Partnership with CIDRAPChana A Sacks, Jim Wappes, Sonja A Rasmussen, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of Molecular Biology|October 22, 2013
Binding of MgtR, a Salmonella transmembrane regulatory peptide, to MgtC, a Mycobacterium tuberculosis virulence factor: a structural studyFrantz L Jean-Francois, Jian Dai, Lu Yu, et al.
NEJM Evidence|February 6, 2024
<i>NEJM Evidence</i> - A New Journal in the NEJM Group FamilyChana A Sacks, C Corey Hardin, Sharon-Lise Normand, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 28, 2003
A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancyDeborah L Toppmeyer, Murugesan Gounder, Judie Much, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 26, 2003
Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignanciesRobert S DiPaola, Eric Rubin, Deb Toppmeyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working GroupLia Gore, S Percy Ivy, Frank M Balis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2016
Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibodyJean-Marie Michot, Renaud Mazeron, Laurent Dercle, et al.
Molecular Cancer Therapeutics|November 8, 2011
MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosisYan Cheng, Yi Zhang, Li Zhang, et al.
Annals of Internal Medicine|March 6, 2023
<i>Mycobacterium abscessus</i> Cluster in Cardiac Surgery Patients Potentially Attributable to a Commercial Water Purification SystemMichael Klompas, Chidiebere Akusobi, Jon Boyer, et al.
Journal of Bacteriology|May 18, 2010
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratoriesThomas R Ioerger, Yicheng Feng, Krishna Ganesula, et al.
NEJM Evidence|December 17, 2025
Public Health Alerts - A New Section in <i>NEJM Evidence</i>, in Partnership with CIDRAPChana A Sacks, Jim Wappes, Sonja A Rasmussen, et al.
Pageof 10